Six-month open label extension to an efficacy and safety study of Ritalin LA in the treatment of adult patients with childhood-onset ADHD

Mise à jour : Il y a 4 ans
Référence : EUCTR2011-000210-19

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

•To evaluate the long-term safety of Ritalin LA administered once daily for six months during open-label treatment in adults with ADHD.


Critère d'inclusion

  • Adult patients with childhood-onset Attention Deficit Hyperactivity Disorder